Production & Manufacturing
Production & Manufacturing
Merck’s Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates
Merck reported that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, demonstrated significantly higher sustained virologic response (SVR)1 rates in adult patients who previously failed treatment (treatment-failure; HCV RESPOND-2) and...
Production & Manufacturing
Biocon and Pfizer Enter Into Global Commercialization Agreement-Deliver Essential Insulin Treatments to Diabetes Patients Worldwide
Biocon, Asia's premier biotechnology company, and Pfizer Inc., the world's leading biopharmaceutical company, today announced that they have entered into a strategic global agreement for the worldwide commercialization of Biocon's biosimilar versions of Insulin and Insulin analog products:Â Recombinant...
Production & Manufacturing
European vaccine development moves forward
The European Vaccine Initiative, a product development partnership supporting the development of vaccines against diseases of poverty, has brought together to Brussels manufacturers, biotech companies, public/academic researchers, and funding agencies to identify the gaps in vaccine research and development...
Production & Manufacturing
Novartis announces agreement to develop influenza vaccines using revolutionary synthetic genomics technology
Novartis announced today an agreement with Synthetic Genomics Vaccines Inc. (SGVI) to apply "synthetic genomics" technologies to accelerate the production of the influenza seed strains required for vaccine manufacturing. The seed strain is the starter culture of a virus,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read